Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
14.72
-0.03 (-0.20%)
At close: May 30, 2025, 4:00 PM
14.73
+0.01 (0.07%)
After-hours: May 30, 2025, 7:18 PM EDT
Dr. Reddy's Laboratories Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Dr. Reddy's Laboratories stock has a target of 17, which predicts a 15.49% increase from the current stock price of 14.72.
Price Target: $17.00 (+15.49%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 6, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Dr. Reddy's Laboratories is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $17 → $17 | Buy | Maintains | $17 → $17 | +15.49% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $16 → $17 | Buy | Maintains | $16 → $17 | +18.21% | Jul 30, 2024 |
| Barclays | Barclays | Buy Maintains $16 → $16 | Buy | Maintains | $16 → $16 | +10.05% | May 8, 2024 |
| Barclays | Barclays | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +8.70% | Jan 29, 2024 |
| Barclays | Barclays | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | -4.89% | Jun 1, 2023 |
Financial Forecast
Revenue This Year
358.87B
from 325.54B
Increased by 10.24%
Revenue Next Year
355.33B
from 358.87B
Decreased by -0.99%
EPS This Year
72.80
from 67.78
Increased by 7.41%
EPS Next Year
58.36
from 72.80
Decreased by -19.83%
Financial currency is INR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 391.8B | 394.9B | 402.5B | |
| Avg | 358.9B | 355.3B | 387.3B | |
| Low | 309.2B | 318.7B | 368.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 20.3% | 10.0% | 13.3% | |
| Avg | 10.2% | -1.0% | 9.0% | |
| Low | -5.0% | -11.2% | 3.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 93.45 | 86.28 | 77.18 |
| Avg | 72.80 | 58.36 | 74.98 |
| Low | 58.02 | 34.59 | 72.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 37.9% | 18.5% | 32.2% |
| Avg | 7.4% | -19.8% | 28.5% |
| Low | -14.4% | -52.5% | 23.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.